BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 3930949)

  • 1. Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.
    Huber-Lang M; Ekdahl KN; Wiegner R; Fromell K; Nilsson B
    Semin Immunopathol; 2018 Jan; 40(1):87-102. PubMed ID: 28900700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of complement C3a receptor responses by kallikrein-related peptidase 14.
    Oikonomopoulou K; DeAngelis RA; Chen H; Diamandis EP; Hollenberg MD; Ricklin D; Lambris JD
    J Immunol; 2013 Oct; 191(7):3858-66. PubMed ID: 24014879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of complement component C3 after synthesis in U937 cells by a putative protein kinase, casein kinase 2, which is regulated by CD11b: evidence that membrane-bound proteases preferentially cleave phosphorylated C3.
    Nilsson Ekdahl K; Nilsson B
    Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):625-33. PubMed ID: 9371724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.
    Nilsson B; Nilsson Ekdahl K; Avila D; Nilsson UR; Lambris JD
    Biochem J; 1990 May; 268(1):55-61. PubMed ID: 1693076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.
    Nilsson B; Grossberger D; Nilsson Ekdahl K; Riegert P; Becherer DJ; Nilsson UR; Lambris JD
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):715-21. PubMed ID: 1372802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the C3b receptor-binding domain in third component of complement.
    Becherer JD; Lambris JD
    J Biol Chem; 1988 Oct; 263(28):14586-91. PubMed ID: 2971659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin.
    Minta JO; Man D; Movat HZ
    J Immunol; 1977 Jun; 118(6):2192-8. PubMed ID: 864257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third component of complement (C3): structural properties in relation to functions.
    Bokisch VA; Dierich MP; Mūller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1977 Jul; 146(1):257-70. PubMed ID: 301546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of tryptic fragments of human complement factor C3.
    Eggertsen G; Hellman U; Lundwall A; Folkersen J; Sjöquist J
    Mol Immunol; 1985 Aug; 22(8):833-41. PubMed ID: 3930949
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.